1. Home
  2. RBBN vs LXEO Comparison

RBBN vs LXEO Comparison

Compare RBBN & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ribbon Communications Inc.

RBBN

Ribbon Communications Inc.

HOLD

Current Price

$2.76

Market Cap

493.4M

Sector

Technology

ML Signal

HOLD

Logo Lexeo Therapeutics Inc.

LXEO

Lexeo Therapeutics Inc.

HOLD

Current Price

$5.81

Market Cap

418.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBBN
LXEO
Founded
1997
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
493.4M
418.9M
IPO Year
2017
2023

Fundamental Metrics

Financial Performance
Metric
RBBN
LXEO
Price
$2.76
$5.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
9
Target Price
$4.67
$18.44
AVG Volume (30 Days)
1.1M
716.9K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
170.97
39.81
EPS
0.22
N/A
Revenue
N/A
$654,000.00
Revenue This Year
$1.97
N/A
Revenue Next Year
$6.69
N/A
P/E Ratio
$12.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.83
$2.43
52 Week High
$4.29
$10.99

Technical Indicators

Market Signals
Indicator
RBBN
LXEO
Relative Strength Index (RSI) 57.18 43.50
Support Level $2.72 $4.95
Resistance Level $2.93 $6.08
Average True Range (ATR) 0.18 0.33
MACD -0.01 -0.06
Stochastic Oscillator 54.17 16.61

Price Performance

Historical Comparison
RBBN
LXEO

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides communications technology to service providers and enterprises, offering software and high-performance hardware products, network solutions, and services for secure data and voice communications, as well as high-bandwidth networking for residential and enterprise customers across industries such as finance, education, government, utilities, and transportation. It operates through two segments: Cloud and Edge, which generate maximum revenue and deliver software-centric, cloud-native solutions for VoIP, VoLTE, VoNR, and unified communications, and IP Optical Networks, which support growing telecommunications traffic from 5G, distributed cloud computing, and other applications. The Company generates the majority of its revenue from the United States.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Share on Social Networks: